by Naga Chalasani (Editor), Gyongyi Szabo (Editor)
Combines coverage of both alcoholic and nonalcoholic fatty liver disease
Includes the most up-to-date clinical information
Volume editors are senior investigators in the fields of alcoholic and nonalcoholic fatty liver disease
Chapters written by experts in the field

From the Back Cover
This volume is the first text to concisely yet comprehensively cover developments for both alcoholic and non-alcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies.

Written by experts in the field, : Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.

About the Author
Drs. Chalasani and Szabo are senior investigators in the field of fatty liver disease and have had extensive federal funding to investigate these areas. They both hold leadership positions and are recognized as experts in the field of fatty liver disease. For example, Dr. Chalasani is the lead author of the multi-society practice guideline on the diagnosis and management of nonalcoholic fatty liver disease& Dr. Szabo is the president-elect of the American Association for the Study of Liver Disease which is the largest liver society in the world. They are also actively practicing clinicians and thus aware of clinically relevant knowledge gaps in the field.

Number of Illustrations and Tables
11 illus., 36 in colour
Topics
Gastroenterology
Pathology
Hepatology

More info and Hardcover at Springer

Link

[email protected] - 12.6 MB